To investigate the significance of increased DNA pol ζ levels in the response of A375 melanoma cells to cisplatin, we used siRNA to the catalytic subunit REV3L to knockdown DNA pol ζ and studied the effect on cisplatin treatment (Fig. 7c). Here, REV3L is linked to melanoma.